NASDAQ : SINT
Sintx Technologies, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.7 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.40M |
| Enterprise Value | 10.96M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.66M |
| Shares Outstanding | 6.66M |
| Shares Change (YoY) | +138.58% |
| Shares Change (QoQ) | +20.82% |
| Owned by Insiders (%) | 9.01% |
| Owned by Institutions (%) | 22.07% |
| Float | 5.48M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.62 |
| Forward PS | 2.62 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 8.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.36 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -298.87 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -255.86% |
| Return on Assets (ROA) | -74.24% |
| Return on Invested Capital (ROIC) | -94.01% |
| Return on Capital Employed (ROCE) | -156.39% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | $41,563 |
| Profits Per Employee | -$562,500 |
| Employee Count | 32 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 0.48 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -46.39% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 43.90 |
| Average Volume (20 Days) | 33,776 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 136,441 |
| Short Previous Month | 99,732 |
| Short % of Shares Out | 2.05% |
| Short % of Float | 2.49% |
| Short Ratio (days to cover) | 1.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.33M |
| Gross Profit | 703,000 |
| Operating Income | -11.66M |
| Pretax Income | -11.28M |
| Net Income | -18.00M |
| EBITDA | -11.34M |
| EBIT | -11.66M |
| Loss Per Share | -$4.60 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.59M |
| Total Debt | 3.15M |
| Net Cash | 439,000 |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | 4.83M |
| Book Value Per Share | 0.73 |
| Working Capital | 4.05M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -10.12M |
| Capital Expenditures | -217,000 |
| Depreciation & Amortization | 313,000 |
| Net Borrowing | -164,000 |
| Free Cash Flow | -10.34M |
| FCF Per Share | -$1.55 |
Margins
| Measure | Value |
|---|
| Gross Margin | 52.86% |
| Operating Margin | -876.39% |
| Pretax Margin | -848.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -138.58% |
| Shareholder Yield | -138.58% |
| Earnings Yield | -269.08% |
| FCF Yield | -90.17% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $9.25 |
| Price Target Difference | 440.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 213.28% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:200 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -41.8 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |